Issues of pharmacology in pediatric cardiac extracorporeal membrane oxygenation with special reference to analgesia and sedation

Artificial Organs

Volumn 23, Issue 11, 1999, Pages 1015-1019

  Burda, Gudrun ^a   Trittenwein, Gerhard ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Analgesia; Extracorporeal membrane oxygenation; Pharmacology; Sedation

Indexed keywords

ANESTHETICS; BRAIN; OXYGENATION; PEDIATRICS;

ANALGESIA; BARRIERS FUNCTIONS; BLOOD-BRAIN BARRIER; CEREBRAL PERFUSION; DISTRIBUTION VOLUME; DRUG ABSORPTION; EXTRACORPOREAL MEMBRANE OXYGENATION; PAIN RELIEF; PHARMACOLOGY; SEDATION;

RESPIRATORY THERAPY;

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; KETAMINE; NARCOTIC AGENT; PANCURONIUM; PROPOFOL; VECURONIUM;

ANALGESIA; CHILD; CONFERENCE PAPER; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; ELECTROENCEPHALOGRAPHY; EXTRACORPOREAL OXYGENATION; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; PARALYSIS; PEDIATRIC SURGERY; PRIORITY JOURNAL; SEDATION;

EID: 0032743435     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1999.06458.x     Document Type: Conference Paper

References (25)

1. Extracorporeal Life Support Organization (ELSO) 1998 July Registry Report. Ann Arbor, Michigan: University of Michigan Medical Center, 1998.
2. Beyer JE, Sood DE, Asheley LC. Patterns of postoperative analgesic use with adults and children following cardiac surgery. Pain 1983;17:71-8.
3. Anand KJ, Hickey PR. Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. New Engl J Med 1992;326:1-9.
4. Atkinson J, Hamid R, Steward D. General anesthesia with isoflurane for diaphragmatic hernia repair during ECMO. ASAIO J 1994;40:986-9.
5. Marx C. Investigation of increased phenobarbital dose requirements for newborn infants on ECMO: In vitro absorption to ECMO circuit. Pharmacotherapy 1991;11:270.
6. Dagan O, Klein J, Gruenwald C, Bohn D, Barker G, Koren G. Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs. Ther Drug Monit 1993;15:263-6.
7. Rosen DA, Rosen KR, Silvasi DL. In vitro variabilty in fenanyl absorption by different membrane oxygenators. J Cardiothorac Anesth 1990;4:332-5
8. Geiduschek JM, Lynn AM, Bratton SL, Sanders JC, Levy FH, Haberkern CM, O'Rourke PP. Morphine pharmacokinetics during continuous infusion of morphine sulfate for infants receiving extracorporeal membrane oxygenation. Crit Care Med 1997;25:360-4.
9. Leuschen MP, Willen LD, Hoie EB, Bolan DL, Bussey ME, Goodrich PD, Zach TL, Nelson RM Jr. Plasma fentanyl levels in infants undergoing extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 1993;105:885-91.
10. Dagan O, Klein J, Bohn D, Koren G. Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants. Crit Care Med 1994;22:1099-1101.
11. Anderson HL, Coran AG, Drongowski RA, Ha HJ, Bartlett RH. Extracellular fluid and total body water changes in neonates undergoing extracorporeal membrane oxygenation. J Pediatr Surg 1992;27:1003-8.
12. Lindsay CA, Bawdon R, Quigley R. Clearance of ticarcillinclavulanic acid by continuous venovenous hemofiltration in three critically ill children, two with and one without concomitant ECMO. Pharmacotherapy 1996;16:458-62.
13. Inoue S, Ninaga H, Sakamoto N, Kawaguchi M, Furuya H, Kuro M, Touho H, Karasawa S. Regional cerebral hypoperfusion reduces the effect of rectal midazolam in children with moyamoya disease. Mosui 1997;46:1474-8.
14. Short BL, Walker LK, Troystman RJ. Impaired cerebral autoregulation in the newborn lamb during recovery from severe prolonged hypoxia combined with carotid artery and jugular vein ligation. Crit Care Med 1994;22:1262-8.
15. Rosen DA, Rosen KR. Midazolam for sedation in the pediatric intensive care. Intens Care Med 1991;17:515-9.
16. Tobias JD, Deshpande JK, Pietsch JB, Wheeler TJ, Gregory DF. Pentobarbital sedation for patients in the pediatric intensive care unit. South Med J 1995;88(3):290-4.
17. Sato M, Tanaka S, Suzuki K, Kohama A, Fujii C. Complications associated with barbiturate therapy. Resucitation 1989; 17:233-41.
18. Carrasco G, Molina R, Costa J, Soler JM, Cabre L. Propofol vs midazolam in short-medium and long-term sedation of critical ill patients. Chest 1993;103:557-64.
19. Mayer N, Legat K, Weinstabl C, Zimpfer M. Effects of propofol on the function of normal collateral-dependent and ischemic myocardium. Anesth Analg 1993;76:33-9.
20. Hanna JP, Ramundo ML. Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology 1998;50:301-3.
21. Scholz J, Steinfath M, Schulz M. Clinical pharmacokinetics of alfentanil. fentanyl and sufentanil. Clin Pharmacokinet 1996; 31:275-92.
22. Santeiro ML, Christie J, Stromqvist C, Torres BA, Markowsky SJ. Pharmacokinetics of continuous infusion fentanyl in newborns. J Perinatol 1997;17:135-9.
23. Arnold JH, Truog RD, Scavone JM, Fenton T. Changes in the pharmacodynamic response to fentanyl in neonates during continous infusion. J Pediatr 1991;119:639-43.
24. Schindler MB, Bohn DJ, Bryan AC. The effect of single-dose and continuous skeletal muscle paralysis on respiratory system compliance in pediatric intensive care patients. Intens Care Med 1996;22:486-91.
25. Fanconi S, Ensner S, Knecht B. Effects of paralysis with pancuronium bromide on joint mobility in premature infants. J Pediatr 1995;127:134-6.